Clinical Trial Update: APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy) [Phase 3]

View source ↗

Summary

APOLLO-B is a Phase 3 trial evaluating patisiran in transthyretin amyloidosis with cardiomyopathy. The study has completed, and results were posted in October 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloidosis with Cardiomyopathy

Drugs mentioned

• Patisiran (patisiran)

Snippet

Sponsor: Alnylam Pharmaceuticals | Conditions: Transthyretin Amyloidosis (ATTR) With Cardiomyopathy | Phase 3 | Status: COMPLETED | Results posted: 2023-10-18